Vertex Pharmaceuticals Inc. buy Argus
Start price
17.06.24
/
50%
€444.15
Target price
17.06.25
€512.66
Performance (%)
-13.77%
End price
18.06.25
€383.00
Summary
This prediction ended on 18.06.25 with a price of €383.00. The price of Vertex Pharmaceuticals Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.77%. Argus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 0.763% | 0.763% | -14.391% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by Argus for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von Argus gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Argus from $465.00 to $550.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat